We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening

By MedImaging International staff writers
Posted on 25 Nov 2015
The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography.

Breast Magnetic Resonance Imaging (MRI) is widely used for the screening of high-risk patients, and pre-surgical planning, and is the most sensitive imaging technique available for detecting breast cancer. In younger women, and those with dense breasts, MRI can detect cancers that have two or more distinct primary tumors, often in different breast quadrants. Most of the so-called multicentric cancers were discovered in women with heterogeneously dense or very dense breasts, but cancer was also found in 19% of patients with fatty or scattered fibro-glandular tissue.

The researchers reviewed the records of 2,021 patients that had newly-diagnosed breast cancer, had preoperative MRI, and a biopsy. The MRI detected additional cancers that were not found in the mammography, in 14% (285) of the patients. In 25.6% (73) of the 285 patients the MRI revealed one or more additional cancers in a different breast quadrant than the index cancer, or that detected by breast palpation and/or mammography. In 17 of the 73 patients (23.3%) the multicentric cancers were larger than the known index cancer. The MRI scan also detected multicentric cancers larger than 1 cm in 25% of the 73 patients.

Lead author of the study, Chiara Iacconi, MD, Breast Unit, USL1 Massa-Carrara, (Carrara, Italy), said, “Patients with clinically insignificant cancers undergoing potential overtreatment versus patients who may be undertreated is at the heart of the controversy surrounding breast MRI. We believe invasive cancer larger than 1 centimeter is clinically relevant disease. In general, it is accepted that radiation can likely treat invasive cancer less than 1 centimeter, but lesions larger than 1 centimeter, especially invasive carcinomas, may not be reliably treated with conservation. The results show that multicentric cancer detected on breast MRI after mammography appears to represent a larger tumor burden in approximately a quarter of patients and can result in potential changes to cancer grade and treatment.

Related Links:

USL1 Massa-Carrara


Ultrasound Needle Guidance System
SonoSite L25
X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital Radiographic System
OMNERA 300M
Adjustable Mobile Barrier
M-458

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.